ArticleCancer research and treatment2017

CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy.

Dae-Won Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.